Neuromeka Co., Ltd. (KOSDAQ:348340)

Neuromeka Statistics

Total Valuation

Neuromeka has a market cap or net worth of KRW 285.43 billion. The enterprise value is 321.10 billion.

Market Cap	285.43B
Enterprise Value	321.10B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Neuromeka has 11.35 million shares outstanding. The number of shares has increased by 3.26% in one year.

Current Share Class	11.35M
Shares Outstanding	11.35M
Shares Change (YoY)	+3.26%
Shares Change (QoQ)	+14.07%
Owned by Insiders (%)	20.27%
Owned by Institutions (%)	0.31%
Float	9.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.66
PB Ratio	15.56
P/TBV Ratio	15.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.11
EV / Sales	15.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.68

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 3.06.

Current Ratio	0.87
Quick Ratio	0.56
Debt / Equity	3.06
Debt / EBITDA	n/a
Debt / FCF	-1.69
Interest Coverage	-3.40

Financial Efficiency

Return on equity (ROE) is -123.58% and return on invested capital (ROIC) is -16.40%.

Return on Equity (ROE)	-123.58%
Return on Assets (ROA)	-12.03%
Return on Invested Capital (ROIC)	-16.40%
Return on Capital Employed (ROCE)	-36.78%
Revenue Per Employee	147.17M
Profits Per Employee	-160.22M
Employee Count	142
Asset Turnover	0.23
Inventory Turnover	2.89

Taxes

In the past 12 months, Neuromeka has paid 25.20 million in taxes.

Income Tax	25.20M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.11% in the last 52 weeks. The beta is 0.93, so Neuromeka's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+9.11%
50-Day Moving Average	23,038.00
200-Day Moving Average	25,759.25
Relative Strength Index (RSI)	58.26
Average Volume (20 Days)	119,419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neuromeka had revenue of KRW 20.90 billion and -22.75 billion in losses. Loss per share was -2,100.88.

Revenue	20.90B
Gross Profit	2.80B
Operating Income	-17.74B
Pretax Income	-22.73B
Net Income	-22.75B
EBITDA	-15.16B
EBIT	-17.74B
Loss Per Share	-2,100.88

Balance Sheet

The company has 20.41 billion in cash and 56.05 billion in debt, giving a net cash position of -35.64 billion or -3,140.73 per share.

Cash & Cash Equivalents	20.41B
Total Debt	56.05B
Net Cash	-35.64B
Net Cash Per Share	-3,140.73
Equity (Book Value)	18.34B
Book Value Per Share	1,615.53
Working Capital	-5.93B

Cash Flow

In the last 12 months, operating cash flow was -18.75 billion and capital expenditures -14.41 billion, giving a free cash flow of -33.16 billion.

Operating Cash Flow	-18.75B
Capital Expenditures	-14.41B
Free Cash Flow	-33.16B
FCF Per Share	-2,921.77

Margins

Gross margin is 13.41%, with operating and profit margins of -84.89% and -108.87%.

Gross Margin	13.41%
Operating Margin	-84.89%
Pretax Margin	-108.75%
Profit Margin	-108.87%
EBITDA Margin	-72.56%
EBIT Margin	-84.89%
FCF Margin	n/a

Dividends & Yields

Neuromeka does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.26%
Shareholder Yield	n/a
Earnings Yield	-7.97%
FCF Yield	-11.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neuromeka has an Altman Z-Score of 0.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.88
Piotroski F-Score	2